The prosurvival protein BAG3: a new participant in vascular homeostasis.

Published online

Journal Article

Bcl2-associated athanogene 3 (BAG3), is constitutively expressed in a few normal cell types, including myocytes, peripheral nerves and in the brain, and is also expressed in certain tumors. To date, the main studies about the role of BAG3 are focused on its pro-survival effect in tumors through various mechanisms that vary according to cellular type. Recently, elevated concentrations of a soluble form of BAG3 were described in patients affected by advanced stage of heart failure (HF), identifying BAG3 as a potentially useful biomarker in monitoring HF progression. Despite the finding of high levels of BAG3 in the sera of HF patients, there are no data on its possible role on the modulation of vascular tone and blood pressure levels. The aim of this study was to investigate the possible hemodynamic effects of BAG3 performing both in vitro and in vivo experiments. Through vascular reactivity studies, we demonstrate that BAG3 is capable of evoking dose-dependent vasorelaxation. Of note, BAG3 exerts its vasorelaxant effect on resistance vessels, typically involved in the blood pressure regulation. Our data further show that the molecular mechanism through which BAG3 exerts this effect is the activation of the PI3K/Akt signalling pathway leading to nitric oxide release by endothelial cells. Finally, we show that in vivo BAG3 administration is capable of regulating blood pressure and that this is dependent on eNOS regulation since this ability is lost in eNOS KO animals.

Full Text

Duke Authors

Cited Authors

  • Carrizzo, A; Damato, A; Ambrosio, M; Falco, A; Rosati, A; Capunzo, M; Madonna, M; Turco, MC; Januzzi, JL; De Laurenzi, V; Vecchione, C

Published Date

  • October 20, 2016

Published In

Volume / Issue

  • 7 / 10

Start / End Page

  • e2431 -

PubMed ID

  • 27763645

Pubmed Central ID

  • 27763645

Electronic International Standard Serial Number (EISSN)

  • 2041-4889

Digital Object Identifier (DOI)

  • 10.1038/cddis.2016.321


  • eng

Conference Location

  • England